Bruce Booth's most recent trade in Kymera Therapeutics Inc was a trade of 85,862 Common Stock done at an average price of $93.2 . Disclosure was reported to the exchange on Dec. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 93.20 per share. | 10 Dec 2025 | 85,862 | 3,980,176 | - | 93.2 | 8,002,338 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 92.41 per share. | 10 Dec 2025 | 47,349 | 4,066,038 | - | 92.4 | 4,375,521 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 88.64 per share. | 10 Dec 2025 | 31,459 | 4,141,757 | - | 88.6 | 2,788,526 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 89.25 per share. | 10 Dec 2025 | 17,825 | 4,123,932 | - | 89.2 | 1,590,881 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 93.20 per share. | 10 Dec 2025 | 16,338 | 686,477 | - | 93.2 | 1,522,702 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 90.14 per share. | 10 Dec 2025 | 10,545 | 4,113,387 | - | 90.1 | 950,526 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 92.41 per share. | 10 Dec 2025 | 9,060 | 702,815 | - | 92.4 | 837,235 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 88.64 per share. | 10 Dec 2025 | 5,979 | 717,267 | - | 88.6 | 529,979 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 91.23 per share. | 10 Dec 2025 | 5,125 | 3,975,051 | - | 91.2 | 467,554 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 89.25 per share. | 10 Dec 2025 | 3,391 | 713,876 | - | 89.3 | 302,647 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 90.14 per share. | 10 Dec 2025 | 2,001 | 711,875 | - | 90.1 | 180,370 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 91.23 per share. | 10 Dec 2025 | 976 | 685,501 | - | 91.2 | 89,040 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 91.04 per share. | 10 Dec 2025 | 570 | 3,974,481 | - | 91.0 | 51,893 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 91.04 per share. | 10 Dec 2025 | 108 | 685,393 | - | 91.0 | 9,832 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.69 per share. | 21 Oct 2025 | 25,327 | 2,309,118 | - | 35.7 | 903,921 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 21 Oct 2025 | 22,339 | 2,360,156 | - | 32.7 | 730,262 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 21 Oct 2025 | 19,948 | 2,340,208 | - | 33.9 | 675,639 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 34.91 per share. | 21 Oct 2025 | 5,763 | 2,334,445 | - | 34.9 | 201,186 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.69 per share. | 21 Oct 2025 | 5,316 | 686,584 | - | 35.7 | 189,728 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 21 Oct 2025 | 4,688 | 697,297 | - | 32.7 | 153,251 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 21 Oct 2025 | 4,187 | 693,110 | - | 33.9 | 141,814 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 34.91 per share. | 21 Oct 2025 | 1,210 | 691,900 | - | 34.9 | 42,241 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.42 per share. | 21 Oct 2025 | 83 | 2,309,035 | - | 36.4 | 3,023 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.41 per share. | 21 Oct 2025 | 17 | 686,567 | - | 36.4 | 619 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.84 per share. | 16 Oct 2025 | 73,296 | 2,492,176 | - | 32.8 | 2,407,041 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.69 per share. | 16 Oct 2025 | 45,117 | 2,565,472 | - | 31.7 | 1,429,758 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 16 Oct 2025 | 28,821 | 2,450,467 | - | 32.1 | 925,154 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.33 per share. | 16 Oct 2025 | 25,788 | 2,382,495 | - | 32.3 | 833,726 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.71 per share. | 16 Oct 2025 | 21,451 | 2,429,016 | - | 32.7 | 701,662 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.79 per share. | 16 Oct 2025 | 20,485 | 2,408,283 | - | 31.8 | 651,218 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.84 per share. | 16 Oct 2025 | 15,384 | 725,006 | - | 32.8 | 505,211 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 16 Oct 2025 | 12,888 | 2,479,288 | - | 33.4 | 430,201 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.69 per share. | 16 Oct 2025 | 9,470 | 740,390 | - | 31.7 | 300,104 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 16 Oct 2025 | 8,596 | 2,610,589 | - | 30.1 | 259,169 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 16 Oct 2025 | 6,049 | 716,252 | - | 32.1 | 194,173 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.33 per share. | 16 Oct 2025 | 5,412 | 701,985 | - | 32.3 | 174,970 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.71 per share. | 16 Oct 2025 | 4,503 | 711,749 | - | 32.7 | 147,293 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.79 per share. | 16 Oct 2025 | 4,300 | 707,397 | - | 31.8 | 136,697 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 16 Oct 2025 | 2,705 | 722,301 | - | 33.4 | 90,293 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 16 Oct 2025 | 1,804 | 749,860 | - | 30.2 | 54,391 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.47 per share. | 16 Oct 2025 | 248 | 2,428,768 | - | 33.5 | 8,301 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.46 per share. | 16 Oct 2025 | 52 | 711,697 | - | 33.5 | 1,740 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.37 per share. | 10 Oct 2025 | 65,726 | 2,649,217 | - | 30.4 | 1,996,099 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.32 per share. | 10 Oct 2025 | 44,048 | 2,719,526 | - | 30.3 | 1,335,535 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.12 per share. | 10 Oct 2025 | 30,032 | 2,619,185 | - | 31.1 | 934,596 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 10 Oct 2025 | 16,727 | 2,763,574 | - | 30.0 | 501,475 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.37 per share. | 10 Oct 2025 | 13,795 | 757,967 | - | 30.4 | 418,954 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.32 per share. | 10 Oct 2025 | 9,245 | 772,724 | - | 30.3 | 280,308 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.12 per share. | 10 Oct 2025 | 6,303 | 751,664 | - | 31.1 | 196,149 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 10 Oct 2025 | 4,082 | 2,715,444 | - | 31.0 | 126,664 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 10 Oct 2025 | 3,511 | 781,969 | - | 30.0 | 105,260 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.03 per share. | 10 Oct 2025 | 857 | 771,867 | - | 31.0 | 26,593 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 10 Oct 2025 | 501 | 2,714,943 | - | 30.0 | 15,005 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 10 Oct 2025 | 105 | 771,762 | - | 30.0 | 3,145 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 03 Oct 2025 | 31,198 | 2,790,054 | - | 30 | 935,940 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 03 Oct 2025 | 9,753 | 2,780,301 | - | 29.9 | 292,102 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 03 Oct 2025 | 6,548 | 787,527 | - | 30 | 196,440 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 03 Oct 2025 | 2,047 | 785,480 | - | 30.0 | 61,308 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.09 per share. | 29 Sep 2025 | 54,637 | 2,831,656 | - | 30.1 | 1,644,027 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.09 per share. | 29 Sep 2025 | 11,468 | 796,259 | - | 30.1 | 345,072 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 29 Sep 2025 | 10,239 | 2,821,417 | - | 30.1 | 307,784 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 29 Sep 2025 | 2,149 | 794,110 | - | 30.1 | 64,599 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 29 Sep 2025 | 165 | 2,821,252 | - | 30.0 | 4,942 | Common Stock |
| Sionna Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.94 per share. | 29 Sep 2025 | 35 | 794,075 | - | 29.9 | 1,048 | Common Stock |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 4,808,896 | 0 | - | - | Common Stock | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 1,027,978 | 0 | - | - | Common Stock | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 48,393 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 34,612 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 18,068 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 13,928 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 12,155 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 9,713 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 7,577 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Aug 2025 | 5,000 | 0 | - | - | Common Stock | |
| Kymera Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Sionna Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 19,959 | 19,959 | - | - | Non-Qualified Stock Option (right to buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 48,393 | 48,393 | - | - | Stock Option Award (Right to Buy) | |
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 2,886,293 | 2,886,293 | - | - | Common Stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,806,317 | 0 | - | - | Series A convertible preferred stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,298,332 | 0 | - | - | Series B convertible preferred stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,092,504 | 0 | - | - | Series C convertible preferred stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 1,051,051 | 0 | - | - | Series Seed convertible preferred stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 747,727 | 747,727 | - | - | Common Stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | 10 Feb 2025 | 61,463 | 0 | - | - | Series C convertible preferred stock | ||
| Sionna Therapeutics Inc | Bruce Booth | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Feb 2025 | 60,000 | 807,727 | - | 18 | 1,080,000 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 38.48 per share. | 09 Jul 2024 | 183,868 | 4,269,602 | - | 38.5 | 7,075,241 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.26 per share. | 09 Jul 2024 | 96,386 | 4,173,216 | - | 39.3 | 3,784,114 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 37.41 per share. | 09 Jul 2024 | 41,763 | 4,453,470 | - | 37.4 | 1,562,354 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 38.48 per share. | 09 Jul 2024 | 38,606 | 743,484 | - | 38.5 | 1,485,559 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.40 per share. | 09 Jul 2024 | 28,718 | 4,495,233 | - | 36.4 | 1,045,335 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 09 Jul 2024 | 24,449 | 4,523,951 | - | 35.6 | 869,651 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.26 per share. | 09 Jul 2024 | 20,238 | 723,246 | - | 39.3 | 794,544 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 37.41 per share. | 09 Jul 2024 | 8,769 | 782,090 | - | 37.4 | 328,048 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.40 per share. | 09 Jul 2024 | 6,030 | 790,859 | - | 36.4 | 219,492 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 09 Jul 2024 | 5,133 | 796,889 | - | 35.6 | 182,581 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.35 per share. | 12 Jun 2024 | 11,838 | 4,558,827 | - | 35.3 | 418,473 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 34.98 per share. | 12 Jun 2024 | 8,430 | 4,548,400 | - | 35.0 | 294,881 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.35 per share. | 12 Jun 2024 | 2,485 | 804,212 | - | 35.4 | 87,845 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.02 per share. | 12 Jun 2024 | 1,997 | 4,556,830 | - | 36.0 | 71,932 | Common Stock |